Aortic Stenosis is a Serious and Widespread Condition; The AI-ECG Algorithm Offers a Powerful Diagnostic Solution Designed ...

AbbVie’s telisotuzumab adizutecan achieved an ORR of 63% in EGFR-mutant NSCLC patients, with current ADC options in this ...

Whether they’re suffering from red, itchy eyes during allergy season, dealing with the discomfort of ear wax buildup or ...

Introduction: The global botulinum toxin market has evolved from being a beauty-industry phenomenon to becoming a ...

$1.5 million is the 'magic number' for retirement savings—here's how long it lasts in every U.S. state ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), ...

The growth in the historical period was largely attributed to the increasing prevalence of pelvic cancers, the aging population, the rise in cervical cancer cases, government initiatives, and ...

Genmab A/S announced today that it will present new research from its comprehensive development program evaluating its late-stage portfolio at the 2025 American Society of Clinical Oncology (ASCO) ...

As Advocate Health launches its plan to replace its South Side Advocate Trinity Hospital with a brand-new building containing ...

Before his stint at AbbVie, Gandor spent more than a decade at Takeda ... “We can’t have this world where we continue to have one brand-centric campaign that we think is going to apply to everybody,” ...

AbbVie ABBV is a genuine cash flow producer ... a robust drug pipeline in play, and a brand new regulatory “green light” for its lung cancer drug Emrelis, supporting the rationale that ABBV ...

An AbbVie drug gives patients a new choice as the ... Approval of the drug, telisotuzumab vedotin, brand name Emrelis, covers the treatment of non-squamous NSCLC that is locally advanced or ...